These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27128373)

  • 1. Alzheimer's Disease Risk Genes and Lipid Regulators.
    El Gaamouch F; Jing P; Xia J; Cai D
    J Alzheimers Dis; 2016 Apr; 53(1):15-29. PubMed ID: 27128373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of amyloid beta in lipid homeostasis.
    Grösgen S; Grimm MO; Friess P; Hartmann T
    Biochim Biophys Acta; 2010 Aug; 1801(8):966-74. PubMed ID: 20452461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease.
    Hirsch-Reinshagen V; Wellington CL
    Curr Opin Lipidol; 2007 Jun; 18(3):325-32. PubMed ID: 17495608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
    Poirier J
    Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipids in Amyloid-β Processing, Aggregation, and Toxicity.
    Morgado I; Garvey M
    Adv Exp Med Biol; 2015; 855():67-94. PubMed ID: 26149926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Lipids and Membranes in the Pathogenesis of Alzheimer's Disease: A Comprehensive View.
    Penke B; Paragi G; Gera J; Berkecz R; Kovács Z; Crul T; VÍgh L
    Curr Alzheimer Res; 2018; 15(13):1191-1212. PubMed ID: 30207230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid Biomarkers in Alzheimer's Disease.
    Zarrouk A; Debbabi M; Bezine M; Karym EM; Badreddine A; Rouaud O; Moreau T; Cherkaoui-Malki M; El Ayeb M; Nasser B; Hammami M; Lizard G
    Curr Alzheimer Res; 2018 Feb; 15(4):303-312. PubMed ID: 28474568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol-related genes in Alzheimer's disease.
    Wollmer MA
    Biochim Biophys Acta; 2010 Aug; 1801(8):762-73. PubMed ID: 20580938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of brain-derived extracellular vesicle lipids in Alzheimer's disease.
    Su H; Rustam YH; Masters CL; Makalic E; McLean CA; Hill AF; Barnham KJ; Reid GE; Vella LJ
    J Extracell Vesicles; 2021 May; 10(7):e12089. PubMed ID: 34012516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking lipids to Alzheimer's disease: cholesterol and beyond.
    Di Paolo G; Kim TW
    Nat Rev Neurosci; 2011 May; 12(5):284-96. PubMed ID: 21448224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions.
    Fabelo N; Martín V; Marín R; Moreno D; Ferrer I; Díaz M
    Neurobiol Aging; 2014 Aug; 35(8):1801-12. PubMed ID: 24613671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid metabolism in Alzheimer's disease.
    Liu Q; Zhang J
    Neurosci Bull; 2014 Apr; 30(2):331-45. PubMed ID: 24733655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ABC transporters in the pathology of Alzheimer's disease.
    Zhao Y; Hou D; Feng X; Lin F; Luo J
    Rev Neurosci; 2017 Feb; 28(2):155-159. PubMed ID: 27997355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of lipids in Alzheimer's disease.
    Lim WL; Martins IJ; Martins RN
    J Genet Genomics; 2014 May; 41(5):261-74. PubMed ID: 24894353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.
    Haughey NJ; Bandaru VV; Bae M; Mattson MP
    Biochim Biophys Acta; 2010 Aug; 1801(8):878-86. PubMed ID: 20452460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?
    Katsel P; Li C; Haroutunian V
    Neurochem Res; 2007; 32(4-5):845-56. PubMed ID: 17342407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism.
    Papassotiropoulos A; Streffer JR; Tsolaki M; Schmid S; Thal D; Nicosia F; Iakovidou V; Maddalena A; Lütjohann D; Ghebremedhin E; Hegi T; Pasch T; Träxler M; Brühl A; Benussi L; Binetti G; Braak H; Nitsch RM; Hock C
    Arch Neurol; 2003 Jan; 60(1):29-35. PubMed ID: 12533085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.